Clinical protocol
RTOG 0924: Androgen Deprivation Therapy and High Dose Radiotherapy with or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
NRG Oncology / RTOG
DoseLab summary
NRG Oncology's page for RTOG 0924, a phase 3 trial of androgen deprivation and high-dose radiotherapy with or without whole-pelvic radiotherapy.
Why this is useful
The RTOG whole-pelvis versus prostate-only trial — the protocol to read for pelvic nodal prostate planning, including its own normal-tissue limits. Protocol documents are available via the NCI CTSU.
Reference details
- Title
- RTOG 0924: Androgen Deprivation Therapy and High Dose Radiotherapy with or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
- Authors / organization
- NRG Oncology / RTOG
- Publication / protocol
- Protocol, RTOG 0924
- Version
- Pending verification
- Year
- Pending verification
- DOI
- Pending verification
- Disease sites
- Prostate
- Topics
- Prostate, Pelvic nodes, Protocols, RTOG, NRG, Dose Constraints
- Fractionation context
- Conventional (prostate and pelvic nodes)
- Last reviewed by DoseLab
- Pending verification